Development of new scaffolds as reversible tissue transglutaminase inhibitors, with improved potency or resistance to glutathione addition.

ABSTRACT: Previous studies within our group have yielded a class of cinnamoyl-based competitive reversible inhibitors for tissue transglutaminase (TG2), with K_i values as low as 1.0 μM (compound CP4d). However, due to the electrophilic nature of their alkene moiety, this class of inhibitors is susceptible to nucleophilic attack by glutathione, a key element in cellular metabolism and toxicity response. To address this issue, we made several modifications to the inhibitor scaffold, ultimately showing that a bis(triazole) scaffold increased resistance to nucleophilic attack, with compound 27d being the most potent (K_i = 10 μM). In the process of reducing reactivity, we also prepared a new class of inhibitors, replacing the alkene of CP4d with an

SUBMITTER: Apperley KYP 

PROVIDER: S-EPMC6072418 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature